Drugs / CAR20.19.22
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05094206 | Jun 2022 → Jan 2024 | B-cell chronic lymphocytic leukemia | Medical College of Wisconsin | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR20.19.22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05094206 ↗ |
| Modality | Cell therapy | “Anti-CD20, Anti-CD19, Anti-CD22 CAR (CAR20.19.22) T-cells” NCT05094206 ↗ |
| Route | Intravenous | “by IV injection” NCT05094206 ↗ |